EHSIOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31

Elite Health Systems Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026

$0.76+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $21.68M
P/E (TTM): –
Dividend yield: –

Elite Health Systems Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	1.02	0	0	0	1.06	3.17	3.07	3.42	3.41	–	–	–	–	–	–	–	–
Cost of Revenue	0.91	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Gross Profit	0.12	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Admin	3.96	1.79	0.77	1.39	1.06	1.20	1.23	1.29	1.26	1.31	1.23	1.18	0.99	1.03	0.95	0.98	0.88
Advertising Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–	–
Operating Expenses	–	–	0.77	1.39	1.15	1.56	1.58	3.29	2.73	2.60	2.43	1.87	0.99	1.71	1.83	1.58	1.29
Total Costs & Expenses	–	1.79	0.77	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Income	-3.84	-1.79	-0.77	-1.39	-0.09	1.62	1.49	0.13	0.69	0.61	0.54	0.74	-0.99	0.25	0.23	0.33	0.18
Interest Expense	–	–	0.00	0	0.00	0.03	0.09	0.11	0.15	0.16	0.18	0.18	0.02	0.20	0.18	0.36	0.29
Interest & Investment Income	–	–	–	–	0	0.00	0.01	0.07	0.01	0.01	0	0	0.01	0.03	0.01	0.01	0.01
Income from Equity Investments	0	-0.43	0.03	-0.12	-0.02	-0.81	-1.39	-0.74	-0.10	0.64	0.29	0.01	-0.03	0.06	0.03	-0.04	0
Other Non-Operating Income	-3.97	-0.43	-0.05	-0.15	-0.47	-0.76	–	–	–	–	–	–	–	–	–	–	–
Asset Impairment Charges	3.98	0	0	0.32	0	–	–	–	0	0.22	0	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	0	-0.66	0	–	0.14	–	0	0.93	0	0	–
Pretax Income	-7.80	-2.22	-0.82	-1.53	-0.55	0.86	0.15	-0.61	0.44	0.88	0.65	0.80	-1.03	1.09	0.09	-0.06	0.07
Income Tax Expense	0	-0.16	0	0.04	0.42	0.32	0.01	-0.19	-0.10	0.34	0.25	0.24	-0.36	0.36	0	0	0
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	0.73	0.09	-0.06	-0.10
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0.03	0.07	-0.18
Net Income incl. Noncontrolling Interests	-7.80	-2.06	-0.82	-1.57	-0.97	0.53	–	–	–	–	–	–	–	–	–	–	–
Minority Interest in Earnings	–	–	0	-0.24	-0.09	0	–	–	–	–	–	–	–	–	–	–	–
Net Income	-7.80	-2.06	-0.82	-1.57	-0.88	0.53	0.14	-0.42	0.54	0.54	0.40	0.56	-0.67	0.73	0.03	0.47	0.07
EPS (Basic)(per share)	-0.35	-0.13	-0.09	-0.09	-0.11	0.07	0.02	-0.05	0.07	0.07	0.05	0.07	-0.09	0.09	0.00	0.06	0.01
EPS (Diluted)(per share)	–	–	-0.17	-0.17	-0.11	0.07	0.02	-0.05	0.07	0.07	0.05	0.07	-0.09	0.09	0.00	0.06	0.01
Shares Outstanding (Basic, Weighted)(shares)	23	15	9.28	7.84	7.79	7.79	7.79	7.79	7.79	7.79	7.80	7.80	7.80	7.80	7.75	7.75	–
Shares Outstanding (Diluted, Weighted)(shares)	23	15	9.28	7.84	7.79	7.79	7.79	7.79	7.79	7.79	7.80	7.80	7.80	7.80	7.75	7.75	–
EBITDA	-3.83	–	–	–	–	–	1.49	1.11	1.82	1.62	1.48	1.41	-0.99	0.67	0.89	1.24	0.96

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 3.2%
Operating margin: -155.6%
Net margin: -261.7%
Return on equity, FY2025: -164.5%

Financial strength

Current ratio: 1.37
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 97.4%

Valuation

P/E ratio: –
Price to sales: 5.81
Price to book: 8.44
Dividend yield: –